Form 8-K - Current report:
SEC Accession No. 0000950170-25-101971
Filing Date
2025-08-04
Accepted
2025-08-04 16:01:29
Documents
10
Period of Report
2025-07-29
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K itrm-20250729.htm   iXBRL 8-K 45637
  Complete submission text file 0000950170-25-101971.txt   149769

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20250729.xsd EX-101.SCH 24813
12 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20250729_htm.xml XML 4519
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 251180109
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)